Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,200 | -44,459 | -29,426 | -14,201 | -59,513 |
| Depreciation Amortization | 609 | 465 | 328 | 165 | 913 |
| Accounts payable and accrued liabilities | 626 | 1,114 | -599 | -192 | 1,644 |
| Other Working Capital | 6,443 | -1,433 | -1,884 | -1,031 | 688 |
| Other Operating Activity | 7,195 | 4,940 | 4,683 | 2,250 | 7,521 |
| Operating Cash Flow | $-45,327 | $-39,373 | $-26,898 | $-13,009 | $-48,747 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -133 | -133 | -58 | -58 | -449 |
| Purchase Of Investment | -89,719 | -64,853 | -49,908 | N/A | -35,031 |
| Sale Of Investment | 70,000 | 45,000 | 25,000 | 15,000 | 48,500 |
| Investing Cash Flow | $-19,852 | $-19,986 | $-24,966 | $14,942 | $13,020 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 43,515 | 215 | 87 | 86 | 561 |
| Other Financing Activity | 69,216 | 69,239 | 69,689 | -11 | -27 |
| Financing Cash Flow | $112,731 | $69,454 | $69,776 | $75 | $534 |
| Beginning Cash Position | 21,981 | 21,981 | 21,981 | 21,981 | 57,174 |
| End Cash Position | 69,533 | 32,076 | 39,893 | 23,989 | 21,981 |
| Net Cash Flow | $47,552 | $10,095 | $17,912 | $2,008 | $-35,193 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,327 | -39,373 | -26,898 | -13,009 | -48,747 |
| Capital Expenditure | -133 | -133 | -58 | -58 | -449 |
| Free Cash Flow | -45,460 | -39,506 | -26,956 | -13,067 | -49,196 |